290 related articles for article (PubMed ID: 32775617)
1. Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer Model.
Hammad M; Cornejo YR; Batalla-Covello J; Majid AA; Burke C; Liu Z; Yuan YC; Li M; Dellinger TH; Lu J; Chen NG; Fong Y; Aboody KS; Mooney R
Mol Ther Oncolytics; 2020 Sep; 18():326-334. PubMed ID: 32775617
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer.
Mooney R; Majid AA; Batalla-Covello J; Machado D; Liu X; Gonzaga J; Tirughana R; Hammad M; Lesniak MS; Curiel DT; Aboody KS
Mol Ther Oncolytics; 2019 Mar; 12():79-92. PubMed ID: 30719498
[TBL] [Abstract][Full Text] [Related]
3. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers.
Draganov DD; Santidrian AF; Minev I; Nguyen D; Kilinc MO; Petrov I; Vyalkova A; Lander E; Berman M; Minev B; Szalay AA
J Transl Med; 2019 Mar; 17(1):100. PubMed ID: 30917829
[TBL] [Abstract][Full Text] [Related]
4. NSCs are permissive to oncolytic
Cornejo Y; Li M; Dellinger TH; Mooney R; Rahman MM; McFadden G; Aboody KS; Hammad M
Oncotarget; 2020 Dec; 11(51):4693-4698. PubMed ID: 33473255
[TBL] [Abstract][Full Text] [Related]
5. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.
Ahmed AU; Thaci B; Tobias AL; Auffinger B; Zhang L; Cheng Y; Kim CK; Yunis C; Han Y; Alexiades NG; Fan X; Aboody KS; Lesniak MS
J Natl Cancer Inst; 2013 Jul; 105(13):968-77. PubMed ID: 23821758
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic human neural stem cells for improved therapeutic delivery to peritoneal ovarian cancer.
Mooney R; Abidi W; Batalla-Covello J; Ngai HW; Hyde C; Machado D; Abdul-Majid A; Kang Y; Hammad M; Flores L; Copeland G; Dellinger T; Han E; Berlin J; Aboody KS
Stem Cell Res Ther; 2021 Mar; 12(1):205. PubMed ID: 33761999
[TBL] [Abstract][Full Text] [Related]
7. A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection.
O'Leary MP; Warner SG; Kim SI; Chaurasiya S; Lu J; Choi AH; Park AK; Woo Y; Fong Y; Chen NG
Mol Ther Oncolytics; 2018 Jun; 9():13-21. PubMed ID: 29988502
[TBL] [Abstract][Full Text] [Related]
8. Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose.
O'Leary MP; Choi AH; Kim SI; Chaurasiya S; Lu J; Park AK; Woo Y; Warner SG; Fong Y; Chen NG
J Transl Med; 2018 Apr; 16(1):110. PubMed ID: 29699566
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.
Thaci B; Ahmed AU; Ulasov IV; Tobias AL; Han Y; Aboody KS; Lesniak MS
Cancer Gene Ther; 2012 Jun; 19(6):431-42. PubMed ID: 22555507
[TBL] [Abstract][Full Text] [Related]
10. Development of Allogeneic Stem Cell-Based Platform for Delivery and Potentiation of Oncolytic Virotherapy.
Nguyen DH; Herrmann T; Härtl B; Draganov D; Minev I; Neuharth F; Gomez A; Alamillo A; Schneider LE; Kleinholz D; Minev B; Santidrian AF
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551636
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy.
Kim CK; Ahmed AU; Auffinger B; Ulasov IV; Tobias AL; Moon KS; Lesniak MS
Mol Ther; 2013 Nov; 21(11):2063-73. PubMed ID: 23883863
[TBL] [Abstract][Full Text] [Related]
12. Maintaining and loading neural stem cells for delivery of oncolytic adenovirus to brain tumors.
Ahmed AU; Ulasov IV; Mercer RW; Lesniak MS
Methods Mol Biol; 2012; 797():97-109. PubMed ID: 21948472
[TBL] [Abstract][Full Text] [Related]
13. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
Tyler MA; Ulasov IV; Sonabend AM; Nandi S; Han Y; Marler S; Roth J; Lesniak MS
Gene Ther; 2009 Feb; 16(2):262-78. PubMed ID: 19078993
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models.
Kim SI; Chaurasiya S; Park AK; Kang S; Lu J; Woo Y; Yin HH; Yin Z; Fong Y; Warner SG
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023064
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Evaluation of Intraventricular Delivery of Therapeutic Neural Stem Cells to Orthotopic Glioma.
Gutova M; Flores L; Adhikarla V; Tsaturyan L; Tirughana R; Aramburo S; Metz M; Gonzaga J; Annala A; Synold TW; Portnow J; Rockne RC; Aboody KS
Front Oncol; 2019; 9():68. PubMed ID: 30838174
[TBL] [Abstract][Full Text] [Related]
16. A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models.
Chaurasiya S; Chen NG; Lu J; Martin N; Shen Y; Kim SI; Warner SG; Woo Y; Fong Y
Cancer Gene Ther; 2020 Apr; 27(3-4):125-135. PubMed ID: 31209267
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses.
Hadryś A; Sochanik A; McFadden G; Jazowiecka-Rakus J
Eur J Pharmacol; 2020 May; 874():172991. PubMed ID: 32044323
[TBL] [Abstract][Full Text] [Related]
18. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.
Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD
J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340
[TBL] [Abstract][Full Text] [Related]
19. Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells.
Osali A; Zhiani M; Ghaebi M; Meymanat M; Esmaeilzadeh A
Pharmacol Res; 2020 Nov; 161():105094. PubMed ID: 32795509
[TBL] [Abstract][Full Text] [Related]
20. Emerging delivery strategy for oncolytic virotherapy.
Zhu J; Ma J; Huang M; Deng H; Shi G
Mol Ther Oncol; 2024 Jun; 32(2):200809. PubMed ID: 38845744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
